Doctor Manan Pareek
Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
Membership:
FESC Member
Biography
Dr. Manan Pareek is an MD, PhD, FAHA, FESC, currently working as a fellow in cardiocascular medicine. He has co-supervised 5 masters theses and co-mentored 6 PhD-students. He has almost 20 years of teaching experience. Dr. Pareek has been a volunteer member of the Danish Society of Cardiology since 2014 where he has authored or co-authored >25 guidelines and been on the endorsement committees for two ESC guidelines (dual antiplatelet therapy and hypertension). He is currently the chair of the Danish Working Group for Acute Coronary Syndromes and a nucleus member in the Working Group for Thrombosis. He has worked with hypertension, biomarkers, antiplatelet drugs, prediction of diabetes, cardiovascular disease, and mortality, and is the principal investigator of ASPIRIN-C3 (NCT05932472), STATIN-C3, and DanRUSH. Finally, Dr. Pareek serves as an editorial fellow at JAMA. He has authored or co-authored >145 peer-reviewed articles.
Contributor content
Presentation
High-sensitivity troponin T and risk of stroke in persons with suspected acute coronary syndrome
Presentation
Body mass index and clinical outcomes in patients with diabetes and stable coronary artery disease in THEMIS
Presentation
High-sensitivity troponin-T concentrations and long-term risk of death in patients with acute pulmonary embolism
Presentation
Serial high-sensitivity troponin-I and long-term risk of myocardial infarction and coronary revascularization in subjects with suspected acute coronary syndrome
Presentation
Blood pressure and clinical outcomes in patients with diabetes and stable coronary artery disease in THEMIS
Presentation
Serial high-sensitivity troponin T concentrations and long-term outcomes in patients with suspected acute coronary syndrome
Presentation
Greater event rates in high-risk patients with a history of heart disease: from the Systolic Blood Pressure Intervention Trial (SPRINT)
Presentation
Marital status, cardiovascular events, and intensive blood pressure lowering among men and women in the Systolic Blood Pressure Intervention Trial
Presentation
Presentation
